Climate Change Data

Environmental Metrics

ESG Focus Areas

• Economic
• Social
• Environmental

Environmental Achievements

• Re-certification of ISO 14001:2015 for environmental management system
• Reduction in hazardous waste generation due to improvements in secondary packaging

Social Achievements

• Opened the educational laboratory “Jorge Di Pascuale” for pharmacy students
• Launched 7 new products, including the first biosimilar oncology product and first generics for high-cost treatments
• Supported FUNDACEN's “Dr. Manuel Sadosky” scholarship program

Governance Achievements

• Successfully completed the bidding of the financial trust Proyecto V.I.D.A. to finance a biotechnology plant
• 2020 Corporate Governance report assessed as “Very Good” by the Comisión Nacional de Valores

Climate Goals & Targets

Environmental Challenges

• Global pandemic impacting new product registration
• Supply chain disruptions due to the pandemic and new projects (UPAP plant and Sputnik V vaccine)

Mitigation Strategies

• Implemented hybrid work system
• Proactive supplier management and coordination for UPAP plant and Sputnik V vaccine projects
• Expanded communication channels for client interaction during pandemic restrictions

Supply Chain Management

Responsible Procurement

• All raw material suppliers comply with Good Manufacturing Practices (GMP)

Climate-Related Risks & Opportunities

Reporting Standards

Frameworks Used: GRI Standards, Sustainable Development Goals (SDG), UN Global Compact, ISO 26000 Standard

Certifications: ISO 14001:2015

Sustainable Products & Innovation

• ZUTRAB (biosimilar)
• EURIT (generic)
• HIPERVAL PLUS (generic)
• ZEVUVIR ABC (co-pack)
• ADDENTA
• TELCARDIA
• INIBCO
• INTRART

Awards & Recognition

• Best Health-care Company 2021 (Fortuna Awards)
• Best Businessperson of the Year 2021 (Marcelo Figueiras, Fortuna Awards)

Environmental Metrics

ESG Focus Areas

• Corporate Governance
• Human Capital
• Clients
• Environment
• Community
• Suppliers

Environmental Achievements

• Maintained ISO 14001:2015 certification
• Decreased power consumption in the UPEF plant's granulator
• Reduced hazardous waste generation (Y2 waste) through improved packaging

Social Achievements

• Provided training to 123 students at the “Jorge Di Pascuale” Educational Laboratory
• Offered Sadosky Scholarships
• Ran internship programs
• Organized a “My First Job” workshop and a talk on preventing STDs and addictions

Governance Achievements

• Increased female representation on the Board of Directors
• Implemented a Corporate Ethics reporting mechanism
• Received a “Very Good” assessment from the Comisión Nacional de Valores on its 2020 Corporate Governance report

Climate Goals & Targets

Environmental Challenges

• Global challenges like the pandemic and armed conflict
• Discontinuation of the Sputnik V vaccine technology transfer agreement
• Supply chain disruptions due to international shipping delays and price fluctuations of raw materials

Mitigation Strategies

• Developed new alliances (e.g., with CanSino Biologics)
• Continued communication with suppliers and developed alternative sourcing strategies
• Made advance procurement based on new lead times

Supply Chain Management

Responsible Procurement

• Supplier evaluation survey (SOP GE 064-Re-08)
• Equal opportunities for tendering

Climate-Related Risks & Opportunities

Reporting Standards

Frameworks Used: GRI Standards, Sustainable Development Goals (SDG), UN Global Compact, ISO 26000 Standard

Certifications: ISO 14001:2015

Awards & Recognition

• Patricio Carballés recognized as one of the best in-house lawyers in Argentina

Environmental Metrics

ESG Focus Areas

• Environmental Sustainability
• Social Impact
• Governance

Environmental Achievements

• Implemented a state-of-the-art device to measure energy consumption in real time at the Pilar Plant.
• Replaced an existing compressor with a new, more efficient one.
• Replaced existing light fixtures with LED lights.
• Decreased hazardous waste generation through improvements in secondary packaging processes.

Social Achievements

• Launched QUARXOM®, the first oral blood thinner developed by Laboratorios Richmond.
• Launched ZUCIVA®, a hypoglycemic drug used to control Type 2 diabetes.
• Launched YDESIB®, a first-line selective and reversible inhibitor for cancer treatment.
• Successfully implemented the SAP system across the whole operations chain.
• Continued collaboration with local communities to foster their development.
• Maintained a safe, inclusive, and enriching work environment for employees.

Governance Achievements

• Increased the participation of female directors on the Board of Directors.
• Maintained ISO 14001:2015 certification.
• Implemented a Corporate Ethics link on the company intranet for anonymous reporting of ethical breaches.

Climate Goals & Targets

Environmental Challenges

• Adverse general economic environment

Mitigation Strategies

• Teamwork guided by corporate pillars of value, access, and sustainability to maintain and strengthen position in the pharmaceutical industry.

Supply Chain Management

Responsible Procurement

• Supplier evaluation survey (SOP GE 064-Re-08)

Climate-Related Risks & Opportunities

Reporting Standards

Frameworks Used: GRI Standards, Sustainable Development Goals (SDG), United Nations Global Compact, ISO 26000 Standard

Certifications: ISO 14001:2015